Publicaciones en colaboración con investigadores/as de University College Cork (55)

2024

  1. Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force

    Allergy: European Journal of Allergy and Clinical Immunology

2023

  1. Cerebral Oximetry Monitoring in Extremely Preterm Infants

    New England Journal of Medicine, Vol. 388, Núm. 16, pp. 1501-1511

  2. EAACI guidelines on the diagnosis of IgE-mediated food allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 12, pp. 3057-3076

  3. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

    Allergy: European Journal of Allergy and Clinical Immunology

  4. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

    World Allergy Organization Journal, Vol. 16, Núm. 3

2022

  1. EAACI guidelines: Anaphylaxis (2021 update)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 2, pp. 357-377

  2. Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases

    Stroke, Vol. 53, Núm. 12, pp. 3741-3750

  3. Managing food allergy: GA2LEN guideline 2022

    World Allergy Organization Journal, Vol. 15, Núm. 9

  4. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  5. Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 3, pp. 991-1003

  6. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750

2021

  1. Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach

    BMC Medical Research Methodology, Vol. 21, Núm. 1

  2. Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review

    World Allergy Organization Journal, Vol. 14, Núm. 3

  3. Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials (European Journal of Clinical Pharmacology, (2021), 77, 1, (1-12), 10.1007/s00228-020-02951-8)

    European Journal of Clinical Pharmacology

  4. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

    European Journal of Clinical Pharmacology, Vol. 77, Núm. 1

  5. Diagnosing, managing and preventing anaphylaxis: Systematic review

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 5, pp. 1493-1506

  6. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  7. Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown

    Frontiers in Pediatrics, Vol. 9

  8. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  9. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4